1. Asthma control in Europe: A real-world evaluation based on an international population- based study 
Lucia Cazzoletti, MSc, Alessandro Marcon, MSc, Christer Janson, MD, Angelo Corsico, MD, PhD, Deborah Jarvis, FFPHM, Isabelle Pin, MD, Simone Accordini, MSc, Enrique Almar, MD, Massimiliano Bugiani, MD, Adriana Carolei, MSc, Isa Cerveri, MD, Enric Duran- Tauleria, BS, MB, David Gislason, MD, Amund Gulsvik, MD, PhD, Rain Jõgi, PhD, Alessandra Marinoni, PhD, Jesús Martínez-Moratalla, MD, Paul Vermeire, MD, Roberto de Marco, PhD 
Journal of Allergy and Clinical Immunology 
Volume 120, Issue 6, Pages (December 2007)
DOI: /j.jaci
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Distribution of asthma control based on ICS use in the last 12 months.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Fig 2
Prevalence of subjects with uncontrolled asthma among ICS users and non-ICS users, according to the country. Estonia was not considered because of the small number of ICS users (n = 3). The P value for heterogeneity between countries is reported in brackets.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4. Fig 3
GINA treatment steps according to controlled, partly controlled, and uncontrolled asthma among ICS users. The numbers close to each bar section are percentages. Step 1, No daily controller; step 2, low-dose ICS, or leukotriene modifier, or theophylline, or cromones; step 3, low-dose ICS combined with leukotriene modifier, or with theophylline, or with long-acting β2-agonist, or medium/high-dose ICS alone; step 4, medium/high-dose ICS combined with leukotriene modifier or with long-acting β2-agonist; step 5, oral steroids.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions